BR112015031856A8 - Aparelho para prover um regime de dosagem de proteína plasmática terapêutica e dispositivo acessível à máquina - Google Patents

Aparelho para prover um regime de dosagem de proteína plasmática terapêutica e dispositivo acessível à máquina

Info

Publication number
BR112015031856A8
BR112015031856A8 BR112015031856A BR112015031856A BR112015031856A8 BR 112015031856 A8 BR112015031856 A8 BR 112015031856A8 BR 112015031856 A BR112015031856 A BR 112015031856A BR 112015031856 A BR112015031856 A BR 112015031856A BR 112015031856 A8 BR112015031856 A8 BR 112015031856A8
Authority
BR
Brazil
Prior art keywords
dosing regimen
plasma protein
therapeutic plasma
dosage
pharmacokinetic
Prior art date
Application number
BR112015031856A
Other languages
English (en)
Other versions
BR112015031856A2 (pt
Inventor
Loew-Baselli Alexandra
Dickey SPOTTS Gerald
Oh Myungshin
Original Assignee
Baxalta GmbH
Baxalta Inc
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52111779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015031856(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta GmbH, Baxalta Inc, Takeda Pharmaceuticals Co filed Critical Baxalta GmbH
Publication of BR112015031856A2 publication Critical patent/BR112015031856A2/pt
Publication of BR112015031856A8 publication Critical patent/BR112015031856A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/20—Probabilistic models
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C99/00—Subject matter not provided for in other groups of this subclass

Abstract

PROVISÃO DE UM REGIME DE DOSAGEM DE DROGA FARMACOCINÉTICA. A presente invenção refere-se a um sistema e a um método para prover um regime de dosagem de droga de proteína plasmática terapêutica que incluem determinar um perfil farmacocinético de um paciente usando um modelo Bayesiano de perfis farmacocinéticos de pacientes amostrados. O sistema e o método exemplificativos também incluem determinar um primeiro regime de dosagem para um primeiro intervalo de dosagem específico incluindo (i) uma primeira dosagem e (ii) um primeiro nível de proteína plasmática terapêutica no paciente sobre um período de tempo com base pelo menos no perfil farmacocinético e determinar um segundo regime de dosagem para um segundo intervalo de dosagem específico incluindo (i) uma segunda dosagem e (ii) um segundo nível de proteína plasma terapêutico no paciente sobre o período de tempo com base pelo menos no perfil farmacocinético. O sistema e o método exemplificativos adicionalmente incluem exibir o primeiro regime de dosagem e o segundo regime de dosagem em um dispositivo de cliente de tal modo que o primeiro regime de dosagem seja exibido em conjunção com o segundo regime de dosagem.
BR112015031856A 2013-06-20 2014-06-20 Aparelho para prover um regime de dosagem de proteína plasmática terapêutica e dispositivo acessível à máquina BR112015031856A8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361837421P 2013-06-20 2013-06-20
US201361840969P 2013-06-28 2013-06-28
US201361881214P 2013-09-23 2013-09-23
PCT/US2014/043517 WO2015006033A1 (en) 2013-06-20 2014-06-20 Providing a pharmacokinetic drug dosing regime

Publications (2)

Publication Number Publication Date
BR112015031856A2 BR112015031856A2 (pt) 2017-07-25
BR112015031856A8 true BR112015031856A8 (pt) 2022-08-30

Family

ID=52111779

Family Applications (3)

Application Number Title Priority Date Filing Date
BR122020013811A BR122020013811A8 (pt) 2013-06-20 2014-06-20 Aparelho para fornecer um regime de dosagem de proteína plasmática terapêutica
BR122022000127A BR122022000127A8 (pt) 2013-06-20 2014-06-20 Método para fornecer um regime terapêutico de dosagem de proteína plasmática e aparelho que compreende instruções armazenadas no mesmo que são configuradas, quando executadas, para fazer com que o aparelho execute um procedimento para determinar um regime de dosagem
BR112015031856A BR112015031856A8 (pt) 2013-06-20 2014-06-20 Aparelho para prover um regime de dosagem de proteína plasmática terapêutica e dispositivo acessível à máquina

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BR122020013811A BR122020013811A8 (pt) 2013-06-20 2014-06-20 Aparelho para fornecer um regime de dosagem de proteína plasmática terapêutica
BR122022000127A BR122022000127A8 (pt) 2013-06-20 2014-06-20 Método para fornecer um regime terapêutico de dosagem de proteína plasmática e aparelho que compreende instruções armazenadas no mesmo que são configuradas, quando executadas, para fazer com que o aparelho execute um procedimento para determinar um regime de dosagem

Country Status (23)

Country Link
US (1) US20140379629A1 (pt)
EP (3) EP3010681B1 (pt)
JP (4) JP2016526542A (pt)
KR (4) KR20220065097A (pt)
CN (2) CN111508557B (pt)
AU (3) AU2014287706B2 (pt)
BR (3) BR122020013811A8 (pt)
CA (1) CA2915472C (pt)
CL (1) CL2015003641A1 (pt)
EA (1) EA037962B1 (pt)
ES (1) ES2882832T3 (pt)
GE (2) GEP20186882B (pt)
IL (3) IL279313B (pt)
MX (3) MX2015017878A (pt)
MY (2) MY176173A (pt)
NZ (1) NZ715216A (pt)
PH (1) PH12015502800A1 (pt)
PL (1) PL3010681T3 (pt)
SA (2) SA515370289B1 (pt)
SG (1) SG11201510515YA (pt)
UA (1) UA118109C2 (pt)
WO (1) WO2015006033A1 (pt)
ZA (1) ZA201600100B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103987321B (zh) * 2011-12-13 2017-06-09 皇家飞利浦有限公司 用于基于结果质量的剂量优化的系统和方法
SG11201502616WA (en) 2012-10-05 2015-05-28 Baysient LLC System and method for providing patient-specific dosing as a function of mathematical models
EP4332839A2 (en) * 2013-12-06 2024-03-06 Bioverativ Therapeutics Inc. Population pharmacokinetics tools and uses thereof
US11181534B2 (en) 2014-04-04 2021-11-23 Bloodworks Routine laboratory and point-of-care (POC) testing for hemostasis
US11062797B2 (en) * 2014-10-10 2021-07-13 Continuous Precision Medicine Method and system for obtaining and using pharmacokinetic data in drug administration
EP3298519A1 (en) * 2015-04-09 2018-03-28 Diane R. Mould Systems and methods for patient-specific dosing
WO2017136583A1 (en) * 2016-02-02 2017-08-10 Versartis, Inc. Growth hormone treatment adherence system
EA201892347A1 (ru) * 2016-04-15 2019-04-30 Баксалта Инкорпорейтед Способ и устройство для предоставления фармакокинетической схемы дозирования лекарственных препаратов
JP6807015B2 (ja) * 2016-06-13 2021-01-06 ソニー株式会社 情報処理装置、情報処理方法、およびプログラム
US10896749B2 (en) * 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
WO2018144373A1 (en) * 2017-02-01 2018-08-09 Shire Human Genetic Therapies, Inc. A physiological sensing and therapeutic administration system and method
BE1027052A1 (fr) 2019-02-14 2020-09-07 Aardex Group Procede d'assistance a la prise ou a l'acte d'un traitement therapeutique
US10970651B1 (en) * 2019-12-02 2021-04-06 Sas Institute Inc. Analytic system for two-stage interactive graphical model selection
KR102420872B1 (ko) * 2020-12-18 2022-07-14 포항공과대학교 산학협력단 강화학습과 약동-약력학 모델을 이용한 연속 약물 투여량 결정 방법
CN113053508A (zh) * 2021-03-29 2021-06-29 深圳市科曼医疗设备有限公司 基于触控屏的交互控制方法及装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07124125A (ja) * 1993-11-04 1995-05-16 S R L:Kk 薬物投与解析システム
CZ81997A3 (en) * 1996-03-20 1997-10-15 Immuno Ag Pharmaceutical preparation for treating disorders connected with blood clotting, process of its preparation and use
WO1998025954A2 (en) * 1996-12-09 1998-06-18 Samuel David Gpi-ceruloplasmin, analogs thereof, and methods of use
MXPA01011429A (es) * 1999-05-11 2003-09-10 Ortho Mcneil Pharm Inc Modelado farmacocinetico y farmacodinamico de administracion de eritropoyetina.
US7860583B2 (en) 2004-08-25 2010-12-28 Carefusion 303, Inc. System and method for dynamically adjusting patient therapy
CA2419244A1 (en) * 2000-09-15 2002-03-21 Virco Bvba System and method for optimizing drug therapy for the treatment of diseases
EP1593080A2 (en) * 2003-02-01 2005-11-09 Baxter International Inc. Wireless medical data communication system and method
EP1642607A1 (en) * 2004-10-04 2006-04-05 Sanofi-Aventis Deutschland GmbH Dose display mechanism for a drug delivery device
JP2006155071A (ja) * 2004-11-26 2006-06-15 Toshiba Sumiden Medical Information Systems Corp 電子カルテ薬物療法指示実施システム
US20060183786A1 (en) * 2005-02-16 2006-08-17 Chi Mei Foundation Hospital Injectable long-acting analgesic composition comprising an ester derivative of ketorolac
EP1958111A4 (en) 2005-11-29 2009-07-08 Childrens Hosp Medical Center OPTIMIZATION AND PERSONALIZATION OF SELECTION AND DOSAGE OF DRUGS
WO2009120991A2 (en) * 2008-03-27 2009-10-01 Medtronic, Inc. Pharmacokinetic and pharmacodynamic tools to define patient specific therapeutic regimens
US8591454B2 (en) * 2008-11-10 2013-11-26 The Invention Science Fund I, Llc Administering a therapeutic agent with more than one taggant
CN102791285A (zh) 2009-12-06 2012-11-21 比奥根艾迪克依蒙菲利亚公司 因子VIII-Fc嵌合多肽和杂交多肽及其使用方法

Also Published As

Publication number Publication date
KR20210110736A (ko) 2021-09-08
JP2022105022A (ja) 2022-07-12
CN111508557B (zh) 2024-03-26
CN111508557A (zh) 2020-08-07
KR20160022874A (ko) 2016-03-02
EA201690048A1 (ru) 2016-05-31
KR102296042B1 (ko) 2021-08-31
SA521430246B1 (ar) 2022-09-14
MY195911A (en) 2023-02-27
MX2020004112A (es) 2020-07-24
JP7398031B2 (ja) 2023-12-14
CN105592973A (zh) 2016-05-18
UA118109C2 (uk) 2018-11-26
JP2019196352A (ja) 2019-11-14
KR20220065097A (ko) 2022-05-19
CA2915472A1 (en) 2015-01-15
AU2014287706A1 (en) 2016-01-21
BR122020013811A2 (pt) 2017-07-25
PL3010681T3 (pl) 2021-11-15
AU2020202664B2 (en) 2022-06-02
PH12015502800B1 (en) 2016-03-14
ZA201600100B (en) 2019-09-25
AU2014287706B2 (en) 2017-10-05
EP3010681B1 (en) 2021-05-19
EP3879534A1 (en) 2021-09-15
IL243208B (en) 2020-06-30
BR122020013811A8 (pt) 2022-08-30
BR122022000127A2 (pt) 2017-07-25
MY176173A (en) 2020-07-24
JP2021061012A (ja) 2021-04-15
NZ715216A (en) 2020-07-31
BR122022000127A8 (pt) 2022-08-30
EP3010681A4 (en) 2017-03-08
JP2016526542A (ja) 2016-09-05
ES2882832T3 (es) 2021-12-02
IL279313B (en) 2022-08-01
AU2017272293A1 (en) 2018-01-04
JP7060291B2 (ja) 2022-04-26
GEP20186882B (en) 2018-07-25
EP3010681A1 (en) 2016-04-27
US20140379629A1 (en) 2014-12-25
SA515370289B1 (ar) 2022-02-02
GEP20196990B (en) 2019-07-10
AU2017272293B2 (en) 2020-01-23
MX2023000359A (es) 2023-02-13
EP3309696A1 (en) 2018-04-18
CN105592973B (zh) 2020-06-19
CA2915472C (en) 2023-09-19
PH12015502800A1 (en) 2016-03-14
SG11201510515YA (en) 2016-01-28
KR102397974B1 (ko) 2022-05-13
IL279313A (en) 2021-01-31
EA037962B1 (ru) 2021-06-16
JP6813237B2 (ja) 2021-01-13
IL243208A0 (en) 2016-02-29
KR20220011217A (ko) 2022-01-27
KR102352133B1 (ko) 2022-01-18
BR112015031856A2 (pt) 2017-07-25
CL2015003641A1 (es) 2016-10-28
MX2015017878A (es) 2016-09-14
AU2020202664A1 (en) 2020-05-14
IL274848A (en) 2020-07-30
WO2015006033A1 (en) 2015-01-15

Similar Documents

Publication Publication Date Title
BR112015031856A8 (pt) Aparelho para prover um regime de dosagem de proteína plasmática terapêutica e dispositivo acessível à máquina
BR112014019386A8 (pt) Dispositivo suplementar para a fixação a um dispositivo de injeção
BR112014018924A8 (pt) Método de gerar uma etiqueta de dosagem customizada para um dispositivo de distribuição de medicamento
MX2014009038A (es) Equipo de combinacion de dosis de seguridad y jeringa de seguridad.
BR112013033943A2 (pt) sistema para uso com uma ou mais fontes de dados filiados de paciente, métodos para atualizar um conjunto de dados de orientação específico de paciente, atualizar uma pluralidade de bancos de dados de dispositivos de interface de paciente, operar um dispositivo de interface de paciente, administrar dados em um sistema, e, dispositivo de interface de paciente
SG10201804607RA (en) System and method for facilitating delivery of patient-care
DK3193981T3 (da) Medikamentadministrationsanordning i form af voluminøst hudplaster med integreret mekanisme til hudsterilisering af injektionssted
BR112018011803A2 (pt) método e mecanismo para a administração de gases incluindo óxido nítrico
IN2015DN03826A (pt)
EA201591679A1 (ru) Способ нетоксического лечения абстиненции, вызванной лекарственным средством
MX2018013503A (es) Aparatos, métodos y sistemas para administrar medicamento utilizando kits de medicamento.
BR112017012448A2 (pt) dispositivo de medição de tempo de repreenchimento capilar, e método para medir tempo de repreenchimento capilar
BR112015024398A2 (pt) aparelho e método para manipular a orientação de um objeto em um dispositivo de exibição
CL2016000641A1 (es) Un controlador para un dispositivo para administrar un medio de contraste que comprende un agente de contraste radiológico en un paciente usando un inyector, y método para determinar el volumen óptimo de un medio de contraste que comprende un agente de contraste radiológico que ha de administrarse en un paciente, antes de la administración.
MX2017008000A (es) Sistema de inyeccion de un solo uso.
BR112018016287A2 (pt) sistema de perfusão, método para administrar diretamente a um paciente em necessidade do mesmo uma dose de um fármaco antineoplásico e recipiente de perfusão
BR112015031139A2 (pt) método e sistema para analisar um grau de uma disfunção autônoma de um sistema nervoso autônomo
EA202190596A3 (ru) Предоставление фармакокинетической схемы дозирования лекарственного средства
BR112017022984A2 (pt) dispositivo para facilitar o posicionamento de um cateter para administrar um medicamento em um paciente que esteja respirando espontaneamente
BR112017010721A2 (pt) seringa e método de identificação de uma dosagem precisa de medicamento em uma câmara de dosagem de uma seringa
TH160649B (th) เครื่องและวิธีการสำหรับข้อกำหนดการให้ขนาดยาทางเภสัชจลนศาสตร์
WANG et al. Study on pharmacokinetics of single and multiple doses of mitiglinide tablets in healthy Chinese volunteers
Friese Staff and student satisfaction with Alberta student pharmacists administering vaccination in the University of Alberta annual influenza campaign
RU2011114635A (ru) Метод расчета дозировки вазопрессорных препаратов
MA38685A1 (fr) Fourniture d'un régime de dosage de médicament pharmacocinétique

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25A Requested transfer of rights approved

Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP)

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: B23P 17/04 , A61M 5/31

Ipc: G16H 20/17 (2006.01), G06N 7/00 (2006.01), A61P 7/

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]